Regulators of the mitotic spindle apparatus are attractive cellular targets for antitumor therapy. The centrosomal protein transforming acidic coiled coil (TACC) 3 is required for spindle assembly and proper chromosome segregation. In this study, we employed an inducible RNA interference approach to downregulate TACC3 expression. We show that TACC3 knock-down in NIH3T3 fibroblasts caused aneuploidy, but failed to overtly impair mitotic progression. TACC3 depletion rather triggered a postmitotic p53-p21 WAF pathway and led to a reversible cell cycle arrest. Similar effects were induced by low concentrations of paclitaxel, a spindle poison used in antitumor therapy. Interestingly, however, and unlike in TACC3-proficient cells, paclitaxel was able to induce strong polyploidy and subsequent apoptosis in TACC3-depleted cells. Even though paclitaxel treatment was associated with the activation of the survival kinase Akt and an antiapoptotic expression of cytoplasmic p21 WAF and cyclin D1, this inhibition of cell death was abrogated by depletion of TACC3. Thus, our data identify TACC3 as a potential target to overcome p21 WAF -associated protection of transformed cells against paclitaxel-induced cell death.
Introduction
The assembly of the mitotic spindle is a tightly controlled process, which ensures proper microtubule-and kinetochore-mediated alignment of chromosomes and their equal distribution upon cell division. During mitosis, the non-attachment of even a single chromosome suffices to activate the mitotic spindle assembly checkpoint, which arrests cells in (pro)metaphase until all chromosomes are properly attached (Kadura and Sazer, 2005) . The spindle assembly checkpoint, however, does not arrest cells permanently, and cells might escape from this block by a process called mitotic slippage. Cells then exit mitosis without proper segregation of sister chromatids, resulting in aneuploidy and chromosomal instability (Brito and Rieder, 2006) . These damaged cells finally arrest in a tetraploid G 1 state by a second, postmitotic checkpoint that is dependent on induction of the tumor suppressor p53 (Blagosklonny, 2006) .
In aneuploid and polyploid cells, p53 induces either cell cycle arrest or apoptosis (Yu and Zhang, 2005) . Cell cycle arrest is mainly controlled via p53-mediated transactivation of the cyclin-dependent kinase (Cdk) inhibitor p21 WAF . Furthermore, p53 mediates G 1 arrest by elevating the protein levels of cyclin D1 in a p21 WAFdependent manner (Chen et al., 1995; Del Sal et al., 1996) . Cyclin D1 was also reported to induce p27 KIP , another Cdk inhibitor (Han et al., 1999) . Interestingly, among the multiple activities of p53, induction of cell cycle arrest and apoptosis seem to interfere with each other. Cell cycle arrest mediated by p21 WAF inhibits apoptosis following p53 expression (Janicke et al., 2007) . In contrast, in the absence of p21 WAF , cells become sensitized to apoptosis by upregulation of several proapoptotic p53 target genes (Stewart et al., 1999) .
Therapeutic interference with the mitotic spindle apparatus is a widely used rationale for the treatment of tumors. The taxane paclitaxel is among the most effective chemotherapeutic agents for patients with prostate, breast and non-small cell lung cancer (Jordan and Wilson, 2004) . Paclitaxel stabilizes microtubules and suppresses their dynamics, resulting in disruption of the microtubule network required for mitosis and cell proliferation. Different concentrations of paclitaxel can trigger distinct effects on both the microtubule network and biochemical pathways. At low concentrations, paclitaxel causes aneuploidy following mitotic delay (Ikui et al., 2005) . These defects are sensed by the postmitotic checkpoint proteins p53 and p21 WAF . On the other hand, high concentrations of paclitaxel lead to a mitotic arrest and cell death from mitosis, independently of the p53-p21 WAF pathway (Giannakakou et al., 2001) . Nevertheless, resistance and a decreased sensitivity to paclitaxel represent an emerging problem in chemotherapy (Abal et al., 2003) . A better understanding of the mediators and processes regulating spindle dynamics might therefore open up new possibilities to overcome chemoresistance.
Members of the transforming acidic coiled-coil (TACC) family function as important structural components of the mitotic spindle apparatus (Gergely, 2002) . TACC proteins regulate centrosome integrity, centrosome-dependent assembly of microtubules and spindle stability during mitosis (Gergely et al., 2003; Cassimeris and Morabito, 2004; Yao et al., 2007) . Moreover, the Xenopus TACC homolog Maskin is involved in translational mRNA regulation during oocyte development (Groisman et al., 2000) . In humans, all three members of the TACC family have been linked to certain cancers. TACC proteins map closely to chromosomal translocation breakpoints that are associated with mammary tumors and multiple myeloma (Still et al., 1999a, b) . Overexpression of TACC1 promotes transformation in vitro (Still et al., 1999a) and in vivo (Cully et al., 2005) . The third family member, TACC3, is highly expressed during the G 2 /M phase of the cell cycle where it localizes to the centrosome and spindle apparatus (Piekorz et al., 2002) . Interestingly, TACC3 aberrations have been recently described in patients with ovarian and non-small cell lung cancer (Lauffart et al., 2005; Jung et al., 2006) .
Using gene targeting in mice, we have recently investigated the function of TACC3. The deficiency of TACC3 results in embryonic lethality, associated with greatly reduced cell numbers and widespread apoptotic cell death (Piekorz et al., 2002) . The reasons for the impaired proliferative capacity of TACC3-deficient cells are largely unknown. Interestingly, the lethality caused by TACC3 deficiency was partially rescued in mice with reduced levels of p53 (Piekorz et al., 2002) . In this study, we demonstrate that downregulation of TACC3 expression in NIH3T3 cells primarily causes a p53-dependent induction of p21 WAF and subsequent cell cycle arrest. Interestingly, TACC3 depletion strongly sensitized cells for paclitaxel treatment. We observed that even in the presence of high levels of antiapoptotic p21 WAF and activation of the survival kinase Akt, paclitaxel could strongly induce cell death upon TACC3 depletion. Our results therefore suggest that TACC3 is a determinant of paclitaxel sensitivity and may represent an attractive target to overcome resistance of tumor cells to paclitaxel-induced chemotherapy.
Results

TACC3 depletion causes aneuploidy and leads to impaired proliferation
To study the cellular role of TACC3, we employed a lentivirus-based and doxycycline (DOX)-controllable siRNA method for downregulation of TACC3 expression. In murine NIH3T3 fibroblasts, expression of a siRNA directed against murine TACC3 (siRNA3m) led to an almost complete depletion of TACC3 protein levels after 4 days of DOX treatment (Figure 1a ). In contrast, TACC3 protein levels did not change in cells transduced with a non-functional TACC3 siRNA (siRNA2m) that was used as a control throughout the study.
Induction of TACC3-siRNA expression in NIH3T3 cells led to increased inhibition of cell proliferation. When an equal number of cells were replated every 4 days, at day 12 of continuous DOX treatment and re-passaging, the cumulative numbers of cells expressing a functional and non-functional siRNA differed by 2.5-fold ( Figure 1b ) and increased to an average 3.4-fold difference on day 20. The decreased proliferation capacity of TACC3-depleted cells was characterized by a progressive decline of diploid cells and a concomitant increase of tetraploid cells (Figure 1c ). Moreover, after 12 days of DOX treatment, nearly 12% of the TACC3-depleted cells became aneuploid, as indicated by a DNA content typical for a nearly subdiploid chromosome number (o2N; Figure 1c ). Cell death was slightly increased following TACC3 depletion as indicated by the percentage of cells undergoing DNA fragmentation within a logarithmic sub-G 1 window. These findings suggest that withdrawal of TACC3 affects the equal separation of chromosomes, thus resulting in aneuploidy.
TACC3 depletion activates p53/p21
WAF signaling in a reversible manner and arrests cells in G 1 and G 2 Genetic inactivation of the mitotically expressed TACC3 gene in mice leads to embryonic lethality that can be in part genetically rescued by lowering p53 expression (Piekorz et al., 2002) . Moreover, following an aberrant mitosis cells usually arrest in G 1 /G 2 in a p53-dependent manner (Vogel et al., 2004; Blagosklonny, 2006) . Therefore, we characterized the molecular mechanisms and consequences of TACC3 gene silencing on p53 activation and cell cycle progression. As demonstrated in Figure 2a , TACC3 depletion led to a robust increase of p53 and p21 WAF protein levels in NIH3T3 cells. In addition, the p21 WAF -related Cdk inhibitor p27 KIP was upregulated (data not shown; Figure 5a ). Remarkably, p53 and its target gene p21 WAF accumulated with every passage, indicating an increasing cell cycle arrest during the course of TACC3 depletion. The impaired cell cycle progression of TACC3-depleted cells was accompanied by high levels of G 1 -associated cyclin D1 and cyclindependent kinase 4 (Cdk4; Figure 2b ). Additionally, TACC3-depleted cells displayed elevated levels of cyclin B1, and most prominently, an increase in Cdk1 phosphorylated at Tyr-15 ( Figure 2c ). This phosphorylation occurs in G 2 and prevents the activation of the Cdk1-cyclin B1 complex required for mitotic entry (Nurse, 1990) . Thus, these data indicate that TACC3-depleted cells that escape from G 1 become arrested at the G 2 /M transition. The notion that this arrest is caused through slippage from a G 1 arrest and not by TACC3 expression and paclitaxel sensitivity L Schneider et al DNA damage was supported by unaltered DNA damage-associated phosphorylation of p53-Ser15 and g-H2AX (data not shown).
Since TACC3 depletion failed to cause overt cell death ( Figure 1c and data not shown), we next asked whether NIH3T3 cells undergo cell cycle arrest in a reversible manner. To this end, we cultured NIH3T3 cells for 8 days in the presence of DOX to deplete TACC3. Thereafter, cells were either kept on DOX, or siRNA expression was terminated by DOX removal. Indeed, proliferation of DOX-free cells comparable to the rate of control cells was restored after several days (Figure 3a) . At the same time, protein levels for both p53 and p21 WAF declined significantly ( Figure 3b ). Thus, p53/p21 WAF -mediated inhibition of cell cycle progression upon TACC3 depletion is reversible and not sufficient to induce widespread cell death.
TACC3-depleted cells are highly susceptible to low-dose paclitaxel treatment despite high p21 WAF levels The chemotherapeutic drug paclitaxel inhibits microtubule depolymerization and impedes proper attachment of microtubules to kinetochores. Since paclitaxel has been reported to trigger a phenotype that is similar to TACC3 depletion, we investigated the effect of TACC3 depletion on the sensitivity of cells to paclitaxel. Treatment of cells with low concentrations of paclitaxel in the presence of TACC3 did not affect aneuploidy, polyploidy or cell death after 24 h (Figure 4a ). Interestingly, TACC3-depleted cells, however, revealed a significantly increased polyploidy after 24 h of paclitaxel treatment. These effects were even more pronounced after 4 days of paclitaxel exposure, which alone was unable to induce strong changes in the DNA content of TACC3-proficient cells, but a highly increased polyploidy and cell death in the absence of TACC3. A similar potentiating effect of the combined paclitaxel treatment and TACC3 depletion was observed when the morphology of the cells was examined. While paclitaxel and TACC3 depletion alone had only minor effects, a dramatic increase in the cell size occurred when cells were treated with paclitaxel in the absence of TACC3 (Figure 4b ). TACC3-deficient cells became mostly binucleated or multinucleated after incubation with paclitaxel. Thus, the depletion of TACC3 strongly sensitizes cells for paclitaxel treatment.
To investigate the molecular mechanism of the increased polyploidy and cell death, we analysed the expression of various cell cycle and apoptosis regulators. Figure 5a demonstrates that paclitaxel treatment ) of cells were replated every 4 days, and cell numbers were determined before each passage. One representative experiment using each two different clones transduced with lentivirus encoding the empty vector, the nonfunctional control siRNA2m or the effective TACC3 siRNA3m is shown. (c) Analysis of cellular DNA content by propidium iodide staining and flow cytometry. Cells were passaged as described in (b) and the percentage of cells with various DNA contents indicative of cell death (DNA fragmentation in sub-G 1 ), aneuploidy (nearly 2N) and polyploidy (>4N) was determined.
TACC3 expression and paclitaxel sensitivity L Schneider et al resulted in clearly elevated levels of p53 and p21 WAF in TACC3-depleted cells as compared to the control cells. Moreover, the expression of cyclin D1 and p27 KIP was strongly elevated in TACC3-depleted cells, whereas in the presence of TACC3, a much weaker induction of these proteins was induced by paclitaxel (Figure 5a ). The subcellular localization of p53, p21 WAF or cyclin D1 was not affected by the simultaneous TACC3 depletion and paclitaxel treatment (Figure 5b ). p53 was predominantly found in the nucleus, corresponding to its function as a transcriptional effector, while p21 WAF was highly induced and found in the cytosol. The cytosolic accumulation of p21 WAF upon treatment with low paclitaxel concentrations depends on its phosphorylation by Akt (Heliez et al., 2003) . Indeed, the levels of Ser-473-phosphorylated (active) Akt were elevated upon TACC3 depletion and/or paclitaxel treatment (Figure 5a ). Consistent with this, we detected increased concentrations of Thr-32-phosphorylated (inactive) FoxO3a, an Akt substrate involved in cell cycle arrest and apoptosis control. Moreover, cyclin D1 and its corresponding kinase Cdk4 (Figure 5b ; data not shown) were found predominantly in the cytosol. This nuclear exclusion is required for G 1 arrest, because only nuclear cyclin D1/Cdk4 complexes are able to inactivate Rb protein and initiate S-phase progression (Gladden and Diehl, 2005) . We also determined the expression of Bcl-2, an important antiapoptotic protein, and of Bax, a proapoptotic Bcl-2 protein triggered by p53. Although Bcl-2 levels remained largely unchanged upon TACC3 depletion as well as upon paclitaxel exposure, we observed a slight but reproducible increase of Bax expression in TACC3-depleted cells as compared to TACC3-proficient cells (Figure 5a ). In summary, these results demonstrate that TACC3 depletion sensitizes cells to paclitaxel-induced cell death by triggering a robust p53 response, even in the presence of high levels of antiapoptotic p21 WAF and active Akt.
Discussion
In this study, we characterized the effects of TACC3 gene silencing on cell cycle progression and show that the absence of TACC3 strongly potentiates the cytotoxic effects of paclitaxel. The depletion of TACC3 TACC3 expression and paclitaxel sensitivity L Schneider et al in NIH3T3 cells resulted in chromosomal misalignment and aneuploidy. Interestingly, TACC3-depleted cells were still able to progress through mitosis, but became arrested postmitotically. Thus, TACC3 depletion primarily leads to the activation of the postmitotic checkpoint and not a mitotic arrest. Therefore, chromosomal segregation defects through TACC3 depletion did not accumulate readily and caused only a transient mitotic delay.
The postmitotic arrest induced upon TACC3 depletion is mediated by a robust induction of the p53-p21 WAF pathway, which is functional in NIH3T3 cells (Figure 6 ). Interestingly, we noted that the knock down of TACC3 had different effects depending on the presence or absence of functional p53. In HeLa cells, for instance, p53 is inactivated leading to an impaired postmitotic checkpoint. In contrast to p53-proficient cells, TACC3 depletion in these cells resulted in a prolonged activation of the spindle assembly checkpoint and an accumulation of mitotic defects. This was accompanied by polyploidization, accumulation of supernumerary centrosomes and cell death from mitosis (Schneider et al., in preparation). The depletion of TACC3 in HeLa cells was also characterized by a delocalization of the chromosomal passenger protein Aurora B and the spindle checkpoint regulator BubR1. In contrast, in TACC3-depleted NIH3T3 cells Aurora B and BubR1 maintained their typical localization at kinetochores during mitosis and for Aurora B at WAF , p27 KIP , Bcl-2 and Bax as well as phosphorylated Akt and its substrate FoxO3a were determined using specific antibodies. Probing for b-actin and a-tubulin was used as loading control. (b) Upregulation and cytoplasmic accumulation of p21 WAF and cyclin D1 increases in TACC3-depleted cells upon paclitaxel treatment. Nuclear and cytoplasmic extracts were prepared and analysed as indicated in (a). Lamin A/C and a-tubulin were used as markers for nuclear (N) and cytoplasmic fractions (C), respectively. Figure  S1 ; data not shown). The minor defects therefore still allow p53-proficient and TACC3-depleted cells to progress through mitosis, albeit with delayed kinetics, a finding that is also supported by the presence of an increased level of mitotic phospho-histone-3 (data not shown).
We found that the postmitotic G 1 arrest following TACC3 depletion in NIH3T3 cells was characterized by strongly increased levels of p21 WAF and cyclin D1. The function of p21 WAF depends on its subcellular localization, which is regulated by differential phosphorylation (Child and Mann, 2006) . In the nucleus, p21
WAF is required for inhibition of cell proliferation. In contrast, localization of p21 WAF in the cytosol has been linked to inhibition of apoptosis and stabilization of cyclin D1/ Cdk4 complexes (Blagosklonny, 2002; Coqueret, 2003; Janicke et al., 2007) . Moreover, stabilization of cyclin D1/Cdk4 through p21 WAF binding renders the complex functionally inactive (Olashaw et al., 2004) . p21
WAF was shown to be induced in a p53-dependent manner by low doses of paclitaxel and then targeted to the cytoplasm through Akt-dependent phosphorylation to relieve the proliferation arrest (Heliez et al., 2003) . Indeed, we observed an elevated Akt activity and a concomitant decrease of active FoxO3a levels in paclitaxel-treated and TACC3-depleted NIH3T3 cells. Activation of the PI3K/Akt pathway promotes survival in cancer cells upon paclitaxel treatment (West et al., 2002) . Moreover, the bypassing of the G 1 arrest by this or other mechanisms would ultimately allow aneuploid TACC3-depleted cells to enter the next cell cycle (Figure 6 ). Additionally, as a backup, the G 2 /M checkpoint becomes activated upon TACC3 depletion as indicated by elevated phospho-Cdk1 and cyclin B1 protein levels. Interestingly, activation of the G 2 arrest after DNA damage by cisplatin or doxorubicin protects cells from subsequent paclitaxel effects during mitosis (Judson et al., 1999; Blagosklonny et al., 2000) . The G 2 checkpoint can be initiated both in a p53-p21 WAFdependent manner and via p53-independent effectors, including Chk1 and Chk2 (Taylor and Stark, 2001; Zachos et al., 2007) . Nevertheless, this arrest can be bypassed through adaptation, which allows cells to enter a next aberrant mitosis (Andreassen et al., 2003) . Consistent with this, we found that inhibition of cell cycle progression in NIH3T3 cells upon TACC3 depletion was not permanent, but reversible upon restoration of TACC3 expression.
The microtubule-stabilizing drug paclitaxel is widely used for the treatment of cancer, but its cellular mechanism of action in cells is dependent on the drug concentration. Similar to TACC3 depletion, low doses of paclitaxel have been reported to induce aneuploidy, resulting in a postmitotic arrest without activation of the spindle assembly checkpoint (Chen and Horwitz, 2002; Abal et al., 2003) . Treatment with low doses of paclitaxel fails to impair mitotic progression and arrests cells postmitotically in a p53-dependent manner also in other cellular systems (Ikui et al., 2005; Blagosklonny, 2006) . This arrest can even become permanent leading to cellular senescence (Blagosklonny et al., 2004 . Consistent with this, depletion of certain centrosomal proteins such as pericentrin in fibroblasts (Srsen et al., 2006; Mikule et al., 2007) or TACC3 in breast carcinoma cells (L Schneider and R Piekorz, unpublished observation) per se also induces senescence characterized by increased p53 and p21 WAF levels. Interestingly, it was shown that low concentrations of paclitaxel dissociate the binding of the chromosomal passenger proteins Mad2 or BubR1 to the APC/C activator p55CDC, thereby weakening the spindle assembly checkpoint and allowing transition into G 1 , whereas high doses sustain complex formation leading to a mitotic block (Ikui et al., 2005) .
An important finding of our study is that, even though depletion of TACC3 or treatment with paclitaxel alone resulted in similar outcomes, the combination of TACC3 depletion and paclitaxel exposure was highly synergistic. Whereas cells expressing a control siRNA were hardly affected by paclitaxel, TACC3 depletion resulted in a strong increase of polyploidy and subsequent apoptosis. This increased cytotoxicity of paclitaxel in TACC3-depleted cells was already observed after 24 h and became most prominent after 4 days of paclitaxel treatment. It is worth mentioning that, unlike with paclitaxel, we did not find a potentiating effect when TACC3-depleted cells were treated with nocodazole, which depolymerizes microtubules and prevents early spindle formation (data not shown).
Whether the increased cell death observed in TACC3-depleted cells upon paclitaxel exposure is solely mediated by a classical caspase-dependent apoptosis, remains unclear. In fact, a p53-dependent and p21 WAFmediated G 1 arrest protects cells from paclitaxelinduced polyploidy and cell death (Stewart et al., 1999) . Although different effects of the Cdk inhibitor p27 KIP , which arrests cells only in G 1 , and p21 WAF , which can additionally arrest cells in G 2 , have been noted (Schmidt et al., 2000) , the high cytosolic p21 WAF levels in TACC3-depleted and paclitaxel-treated cells may primarily play an antiapoptotic role (Janicke et al., 2007) . p21 WAF has been recently reported to interfere with irradiation-induced apoptosis by inhibiting caspase-9 activation, an event that is promoted in presence of active Cdks (Sohn et al., 2006) . The strong induction of p21 WAF might therefore also explain our finding that in TACC3-depleted cells, paclitaxel triggered an only twofold increase of phosphatidylserine exposure, a caspase-dependent apoptotic process. Similarly, the levels of the proapoptotic p53 target Bax were only slightly increased. Intriguingly, paclitaxel treatment of TACC3-depleted cells resulted in considerable DNA fragmentation (six-to sevenfold), but caspase inhibitors could only weakly inhibit this event. These observations therefore argue for additional caspaseindependent pathways that are triggered upon TACC3 depletion and paclitaxel exposure. Nevertheless, our finding that TACC3 depletion strongly sensitizes cells to paclitaxel suggests TACC3 may represent an interesting target to overcome chemoresistance of transformed cells. 
Materials and methods
Cloning of lentiviral constructs for conditional gene suppression of TACC3
The original lentiviral vectors for siRNA expression and the protocol for generation of tTR-KRAB transrepressor-positive target cell lines have been published (Wiznerowicz and Trono, 2003) . Complementary synthetic shRNA oligos consisting of sense-loop-antisense sequences (Operon, Cologne, Germany) were cloned into the shRNA expression vector pLVTH downstream of the H1 promoter as instructed on http:// tronolab.epfl.ch/page58115.html. The RNAi sequences were selected using siRNA prediction software (Whitehead Institute for Biomedical Research, Boston, MA, USA) against the murine TACC3 cDNA (BC003252). In particular, siRNA2m is directed against nucleotides 495-513 (5 0 -TCTTGACTTC CTCAAGCCT-3 0 ), whereas siRNA3m targets nucleotides 1097-1115 (5 0 -GTGGATTATCTGGAGCAGT-3 0 ).
Cell culture and lentiviral transductions 293T and NIH3T3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FCS (Invitrogen, Karlsruhe, Germany), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml of streptomycin. Cells were transduced with lentiviruses essentially as described (Leurs et al., 2003) . In brief, lentiviruses were generated by transfection of 293T cells plated at a density of 4.5 Â 10 6 cells/10 cm dish. The following day, cells were cotransfected with 10 mg each of the lentiviral vector pLVTH and the packaging and envelope encoding plasmids pCMV-dR8.74-psPAX2 and pCR-VSVG using calcium phosphate precipitation. Viral supernatants were supplied 24 h later with 7 mg/ml polybrene (Sigma, Munich, Germany) and used to transduce target cells at a density of 3.5 Â 10 4 cells/3.5 cm plate. Puromycin-selected NIH3T3 cell lines stably expressing the tTR-KRAB transrepressor were used to generate lines expressing the different siRNAs upon treatment with doxycycline (DOX, 5 mg/ml; MP Biomedicals, Eschwege, Germany). For each siRNA, various subclones were analysed throughout this study.
Cell cycle analysis
For determination of cell cycle distribution, cells were stained with propidium iodide (50 mg/ml in 0.1% sodium citrate/0.1% Triton X-100) and treated with 40 mg/ml RNase on ice. The DNA content and percentage of cells in different phases of the cell cycle were assayed by flow cytometry (BD FACScalibur, BD Heidelberg, Germany) and quantified in a linear mode (FL2-A) using winMDI software. Aneuploid cells were defined with a nearly diploid sub-G 1 -DNA-content essentially as described (Chen and Horwitz, 2002) . The percentage of cells undergoing DNA fragmentation (hypodiploid cells in sub-G 1 ) or polyploidy (>4N) was determined in a logarithmic mode (FL3-H).
Confocal laser scanning microscopy Cells were seeded at densities of 6 Â 10 3 /cm 2 and grown in media containing 5 mg/ml DOX. After the indicated time, cells were fixed with methanol/acetone at À201C, and subsequently incubated for 1 h in phosphate-buffered saline containing 4% bovine serum albumin and 0.05% saponine. Cells were stained over night with the anti-a-tubulin (DM1a, 1:500, Sigma) and/ or anti-Aurora B (1:100; BD, Heidelberg, Germany) antibodies. Thereafter, cells were washed and labeled with secondary antibodies (4 mg/ml; Alexa488-and Alexa592-coupled anti-mouse or anti-rabbit IgG (Invitrogen). DNA was detected using DAPI (4,6-diamidino-2-phenylindole, 1 mg/ml; Sigma). Analyses were performed with a Leica TCS SP2/AOBS microscope equipped with a HCX PL APO 63 Â immersion objective and excitation wavelengths of 405, 488 and 594 nm.
Figures shown are projections of recorded z stacks of various dimensions and a resolution of at least 512 Â 512 pixels.
Subcellular fractionation
Cells were homogenized in 500 ml ice-cold extraction buffer (EB; 10 mM HEPES-KOH, pH 8.0, 0.32 M sucrose, 1 mM ethylene glycol-bis(b-aminoethylether)-N,N,N 0 ,N 0 -tetraacetic (EGTA), 25 mM KCl, 5 mM MgCl 2 , 0.1 mM dithiothreitol, 1 mM DNase and protease inhibitor cocktail). Nuclei were isolated by centrifugation (600 g, 10 min), re-suspended in 3 ml nuclear buffer 1 (NE1; 0.25 M sucrose, 10 mM MgCl 2 ) and transferred onto 3 ml NE2 (0.35 M sucrose, 0.5 mM MgCl 2 ). After centrifugation (1450 g, 5 min), nuclei were re-suspended in 300 ml EB containing 2% CHAPS (3-(3-cholamidopropyl)-dimethylammonio-1-propanesulfonate). The crude cytosolic (supernatant) fraction was re-centrifuged (10 000 g, 30 min) to remove mitochondria.
Immunoblotting
Total-cell lysates were prepared in lysis buffer containing 1% NP-40 (nonidet P-40), 50 mM Tris-HCl, pH 8.0, 150 mM NaCl and 2 mM EDTA (ethylenediaminetetraacetic acid). Protein samples were separated by SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride membranes and probed with the following antibodies at a concentration of 1 mg/ml or according to the manufacturer's instructions: antiactin (C4; MP Biomedicals); anti-mouse TACC3 (Piekorz et al., 2002) ; anti-p53 (FL-393), anti-mouse p21 WAF (F5) and anti-cdc2 (sc-54) from Santa Cruz Biotechnology (Heidelberg, Germany); anti-Cdk1-P-Tyr15 from BD Biosciences; anticyclin D1 (Ab3), anti-cyclin D2 (Ab4), anti-cyclin B1 (Ab3), anti-Cdk4 (Ab1), anti-p27 KIP (Ab1), anti-Bax (Ab8); anti-Bcl-2 from Labvision (Fremont, CA, USA); and anti-FoxO3a (phospho-Thr34) from Upstate (Lake Placid, NY, USA). The polyclonal anti-p53 antibody was raised against the fulllength protein and may therefore also detect truncated versions of p53. Signals were visualized with the ECL detection system (GE Healthcare, Freiburg, Germany) following incubation with HRP-coupled secondary antibodies.
Statistical analysis
To evaluate statistical significance, we have performed Student's t-tests. Results are given as means7s.d. P-values below 0.05 were considered significant.
